Validation Excellence for CDMOs: From Regulatory Burden to Business Driver
Join Bryan Ennis, Founder and Chief Quality Officer of Sware, and Bryan Holmes, Vice President of IT at Andelyn Biosciences as they tackle the evolving landscape of validation in CDMO environments, reframing it from a compliance-heavy obligation to a catalyst for operational and business performance.
Featured Resources
The convergence of AI and Quality Management marks a paradigm shift in how Life Sciences organizations meet their GxP obligations. Examine key challenges—from compliance complexities and validation demands to talent shortages and risk management concerns.
Read the WhitepaperAs the life sciences landscape rapidly evolves, technology adoption demands agile validation methods to maintain GxP compliance. Learn how organizations can shift from project-based validation to a process-driven approach, integrating validation into their Quality Management System.
Read the WhitepaperManual computer software validation processes cost life sciences organizations up to 30% in additional project budget. As companies struggle to keep up with a surge of app and software integrations, they incur validation debt: the mounting cost of stretched resources, blanket testing, and missed GxP requirements.
Download the EbookValidation Debt Stops Here
If your organization is ready to embrace the future of life sciences validation, we’re ready to help.